Hansa Biopharma ABStockholm
LEI 549300LLEO25ZJJ3NT91 · XSTO · SE · Business ID 556734-5359
Recent insider sentiment
No open-market buying or selling — last 90 days
Share-award batches are excluded from this read — they’re compensation, not conviction.
0
Open-market buys (90d)
0
Sales (90d)
0
Share awards (90d)
0
Active insiders (90d)
Transactions
| Date | Person | Nature | Volume | Price | Value | Source |
|---|---|---|---|---|---|---|
| 11.03.2026 | Sandra Boström Frithiof — Management | Bought — open marketAcquisition | 1,688 | SEK 29.62 | SEK 49,998.56 | ↗ |
| 16.02.2026 | Michael Bologna — Board member | SoldDisposal via Devin Holden | 2,649 | SEK 39.63 | SEK 104,969.80 | ↗ |
| 13.02.2026 | Michael Bologna — Board member | SoldDisposal via Devin Holden | 138,580 | SEK 40.07 | SEK 5,553,011.46 | ↗ |
| 07.11.2025 | Charles Ballantyne — CFO | Bought — open marketAcquisition | 25,000 | USD 2.83 | USD 70,853.50 | ↗ |
| 28.07.2025 | RENÉE AGUIAR LUCANDER — CEO | Bought — open marketAcquisition | 50,000 | SEK 27.40 | SEK 1,370,000.00 | ↗ |
| 27.07.2025 | RENÉE AGUIAR LUCANDER — CEO | Bought — open marketAcquisition | 1,652,500 | SEK 10.89 | SEK 17,995,725.00 | ↗ |
| 24.07.2025 | RENÉE AGUIAR LUCANDER — CEO | Bought — open marketAcquisition | 100,000 | SEK 27.00 | SEK 2,700,000.00 | ↗ |
| 22.07.2025 | Anne Säfström Lanner — Management | Share award | 15,050 | — | Share award 15,050 shares | ↗ |
| 22.07.2025 | Anne Säfström Lanner — Management | SoldDisposal | 8,056 | SEK 26.42 | SEK 212,839.52 | ↗ |
Active insiders (90d)
No activity in the last 90 days.